On March 8, 2022 Herantis Pharma Plc ("Herantis"), developing disease modifying therapies for Parkinson’s disease, reported that Antti Vuolanto, Chief Operating Officer, will hold a company presentation at (Press release, Herantis Pharma, MAR 8, 2022, View Source,c3520073 [SID1234609656]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Sachs 5th Annual Neuroscience Innovation Forum (Virtual)

The presentation will be held on March 22, 2022

1×1 meetings will be scheduled with the management team during March 21 – 25, 2022

The presentation will be available via a digital library, which is accessible to event participants only. Please contact the conference organizers, or send an email to [email protected], if you wish to schedule a meeting with Herantis.